RNAi Therapy Market: Translating Gene Silencing into Clinical Treatments
The RNAi Therapy Market is devoted to therapeutic approaches based on RNA interference (RNAi)—a natural cellular process whereby small RNA molecules silence specific genes by targeting their mRNA for degradation or translational inhibition. RNAi therapies use synthetic or vector‑delivered small interfering RNAs (siRNAs) or short hairpin RNAs (shRNAs) to selectively reduce expression of...
0 Comments 0 Shares 216 Views 0 Reviews